CM
Crestline Management Portfolio holdings
AUM
$62.6M
This Quarter Return
+9.02%
1 Year Return
-18.06%
3 Year Return
+16.7%
5 Year Return
+67.08%
10 Year Return
+99.86%
AUM
$62.6M
AUM Growth
+$62.6M
(-1.1%)
Cap. Flow
-$5.21M
Cap. Flow
% of AUM
-8.32%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Denali Therapeutics
DNLI
|
$4.2M |
| 2 |
Sana Biotechnology
SANA
|
$1.01M |
Sector Composition
| 1 | Healthcare | 96.9% |
| 2 | Technology | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Denali Therapeutics
DNLI
$2.23B
| $54M | 86.33% | 3,860,732 -300,000 | -7% | -$4.2M |
|
|
2
Sana Biotechnology
SANA
$777M
| $6.61M | 10.56% | 2,420,937 -370,000 | -13% | -$1.01M |
|
3
8x8 Inc
EGHT
$270M
| $1.94M | 3.1% | 990,580 | – | – |
|